先声药业的2024:创新药小幅增长,研发投入下降

财中社
25 Mar

3月24日晚间,港股先声药业(02096)发布2024财年年报,期间实现营业收入66.35亿元,同比增长0.41%;净利润7.33亿元,同比增长2.57%;经调整净利润10.18亿元,同比增长41.65%。次日(3月25日),先声药业开盘后股价就不断走低,午间收盘下跌3.19%,报7.58港元/股,市值188亿港元,下午开盘后继续下行。增速不如同行,创新药多为并购或合作所得《财中社》发现,创新药是...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10